PuraCap Pharmaceutical has acquired Blu Pharmaceutical and Blu Caribe, creating PuraCap International, a joint venture between PuraCap and Dangdai International Group. This deal expands PuraCap’s manufacturing reach beyond soft gelatin capsules to include oral tablet and capsule dosage forms for both the U.S. and global markets. Under PuraCap International, the newly created company will grow and strengthen PuraCap’s manufacturing capabilities over the next several years, accordin...